NASDAQ:CBPO - China Biologic Products Holdings, Inc.
$97.05
 $-0.14
-0.14%
4:00PM EDT
2019-04-18
China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC). The Company offers human albumin for the treatment of shock caused by blood loss trauma or burn, raised intracranial pressure caused by hydrocephalus or trauma, edema or ascites caused by hepatocirrhosis and nephropathy, prevention and treatment of low-density-lipoproteinemia, and neonatal hyperbilirubinemia. It offers human immunoglobulin and IVIG for the treatment of original immunoglobulin deficiency, such as X chain low immunoglobulin, familiar variable immune deficiency, immunoglobulin G secondary deficiency, secondary immunoglobulin deficiency, such as infection and newborn sepsis, and auto-immune deficiency diseases, such as original thrombocytopenia purpura or kawasaki disease. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CBPO     avg for
industry  
  avg for
sector  
42 stocks weight:  263. 16   199. 07   233. 87  
42 stocks rank:  804. 00   1. 43 K 1. 06 K
# analyst opinions:  8. 00   14. 48   14. 09  
mean recommendation:  2. 90   2. 09   2. 01  

quick ratio:  8. 94   5. 29   1. 92  
current ratio:  11. 09   5. 64   2. 40  

target price low:  62. 00   84. 50   115. 74  
target price avg:  88. 55   110. 73   137. 39  
target price high:  115. 00   136. 41   157. 80  
1-yr high:  106. 72   114. 11   138. 85  
last close:  97. 05   87. 56   116. 78  
50-day avg:  87. 17   95. 43   123. 53  
200-day avg:  83. 71   94. 13   121. 20  
1-yr low:  60. 38   72. 67   98. 41  
volume:  357. 05 K 2. 43 M 4. 85 M
50-day avg volume:  254. 49 K 2. 72 M 4. 97 M
200-day avg volume:  264. 73 K 2. 90 M 4. 58 M

1-day return:  -0. 06 % -0. 40 % 0. 07 %
this week return:  0. 68 % -5. 72 % -4. 11 %
12-wk return:  19. 53 % 1. 78 % -0. 04 %
52-wk return:  12. 20 % 10. 81 % 14. 09 %

enterprise value (EV):  2. 96 B 51. 19 B 117. 96 B
market cap:  3. 82 B 43. 00 B 104. 52 B
EBITDA:  169. 40 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  17. 50   4. 34   13. 27  
enterprise/revenue (EV/R):  6. 35   68. 16   13. 68  
total revenue:  466. 88 M 10. 61 B 38. 24 B
total debt:  0. 00   12. 22 B 16. 66 B
net income (common):  124. 98 M 2. 20 B 4. 21 B

shares outstanding:  39. 36 M 570. 91 M 1. 24 B
shares:  17. 73 M 571. 02 M 1. 23 B
shares short:  1. 22 M 9. 93 M 16. 79 M
shares short prior month:  1. 24 M 9. 96 M 16. 58 M
short ratio:  4. 88   5. 31   3. 30  
short % of float:  4. 34 % 5. 81 % 2. 61 %
total cash/share:  24. 20   11. 13   9. 30  
total cash:  952. 41 M 6. 70 B 7. 10 B
free cash flow:  71. 61 M 3. 58 B 4. 74 B
operating cash flow:  103. 94 M 4. 14 B 6. 32 B

book value:  43. 75   12. 76   26. 84  
price/book:  2. 22   3. 08   -1. 74  
gross profits:  320. 09 M 8. 03 B 34. 77 B
operating margins:  31. 31 % -721. 97 % -88. 82 %
EBITDA margins:  36. 28 % 10. 94 % 22. 54 %
profit margins:  27. 43 % 7. 81 % 10. 60 %
gross margins:  68. 56 % 37. 02 % 55. 68 %

1-yr max volatility:  21. 15 % --- ---
1-yr mean volatility:  0. 07 % 0. 03 % 0. 04 %

1-yr EPS:  3. 53   2. 39   4. 08  
forward EPS:  4. 28   3. 97   7. 14  
P/E:  27. 49   13. 59   22. 83  
forward P/E:  22. 52   -20. 05   14. 49  
PE/G:  1. 00   -1. 46   1. 68  
growth:  27. 50 % 126. 81 % 29. 29 %
earnings high:  1. 04   1. 02   1. 63  
earnings avg:  1. 10   0. 76   1. 51  
earnings low:  0. 96   0. 47   1. 39  
revenue high:  124. 50 M 2. 68 B 10. 71 B
revenue avg:  122. 00 M 2. 59 B 10. 49 B
revenue low:  119. 50 M 2. 49 B 10. 25 B
return on assets:  6. 48 % -2. 80 % 5. 29 %
return on equity:  11. 79 % -18. 52 % 7. 38 %
revenue growth:  27. 50 % 92. 55 % 19. 15 %
revenue/share:  13. 22   13. 27   55. 24  

beta (1yr vs S&P500):  0. 65   1. 24   0. 93  
sharpe (1yr):  0. 44   0. 29   0. 60  

held % insiders:  44. 13 % 6. 38 % 3. 38 %
held % institutions:  47. 35 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : CBPO
.   + 13.381 =        13.381 :: INITIAL WEIGHT
.   + 23.008 =         36.39 :: inverse volume-to-price addition
.   + 22.193 =        58.582 :: spline projection addition
.    x 8.216 =        481.33 :: 13 weeks' performance factor
.    x 1.116 =       536.932 :: one-year gains+dividend factor
.    x 1.432 =       768.899 :: industry recommendation factor
.    x 1.018 =       782.734 :: symbol recommendation factor
.    x 1.093 =       855.641 :: EV/R factor
.    x 1.855 =      1587.292 :: return on assets factor
.    x 1.785 =      2833.649 :: return on equity factor
.     x 2.35 =      6657.883 :: revenue growth factor
.    x 2.033 =     13532.984 :: current ratio factor
.    x 1.061 =     14360.226 :: quick ratio factor
.    x 1.098 =     15763.042 :: short ratio factor
.    x 2.022 =      31875.76 :: price-to-book factor
.    x 1.792 =     57123.462 :: EBITDA multiple vs industry factor
.      x 1.1 =     62836.379 :: EBITDA multiple factor
.    x 1.156 =     72616.598 :: 5-day avg > 200-day avg
.     x 1.11 =     80594.209 :: 5-day avg > 50-day avg
.    x 1.041 =     83919.067 :: 50-day avg > 200-day avg
.    x 2.596 =    217846.971 :: P/E weight
.      x 1.0 =    217860.999 :: PE/G factor
.      x 1.7 =    370339.241 :: beta factor
.     x 0.44 =    162861.487 :: sharpe factor
.     x 0.94 =    153074.148 :: target low factor
.    x 0.948 =    145044.648 :: target mean factor
.    x 1.043 =    151282.516 :: target high factor
.    x 1.312 =    198429.468 :: industry 2-weeks return factor
.      x 1.0 =    198337.589 :: overall "drift" factor
.    x 0.789 =    156392.723 :: largest single-day jump factor
.     x 1.01 =    157955.486 :: mean volatility factor
.    x 1.099 =    173597.028 :: 42-day mean volatility factor
.      x 1.0 =    173569.045 :: factor hist industry gain for week 15
.   cubeRoot =        55.782 :: reduced to standardize
.   + 11.396 =        67.178 :: upcoming earnings report
.  + 195.983 =       263.161 :: add/subtract for performance
.                    263.161 :: FINAL WEIGHT for NASDAQ:CBPO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org